nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcium Gluceptate—Hypercalcaemia—Epirubicin—liver cancer	0.0334	0.0334	CcSEcCtD
Calcium Gluceptate—Hypercalcaemia—Doxorubicin—liver cancer	0.0309	0.0309	CcSEcCtD
Calcium Gluceptate—Necrosis—Epirubicin—liver cancer	0.0296	0.0296	CcSEcCtD
Calcium Gluceptate—Abscess—Epirubicin—liver cancer	0.0293	0.0293	CcSEcCtD
Calcium Gluceptate—Arrhythmia—Sorafenib—liver cancer	0.0282	0.0282	CcSEcCtD
Calcium Gluceptate—Necrosis—Doxorubicin—liver cancer	0.0274	0.0274	CcSEcCtD
Calcium Gluceptate—Abscess—Doxorubicin—liver cancer	0.0271	0.0271	CcSEcCtD
Calcium Gluceptate—Delirium—Epirubicin—liver cancer	0.027	0.027	CcSEcCtD
Calcium Gluceptate—Dysgeusia—Sorafenib—liver cancer	0.0269	0.0269	CcSEcCtD
Calcium Gluceptate—Vasodilation procedure—Epirubicin—liver cancer	0.0264	0.0264	CcSEcCtD
Calcium Gluceptate—Vasodilation—Epirubicin—liver cancer	0.0264	0.0264	CcSEcCtD
Calcium Gluceptate—Delirium—Doxorubicin—liver cancer	0.025	0.025	CcSEcCtD
Calcium Gluceptate—Syncope—Sorafenib—liver cancer	0.0246	0.0246	CcSEcCtD
Calcium Gluceptate—Vasodilation—Doxorubicin—liver cancer	0.0244	0.0244	CcSEcCtD
Calcium Gluceptate—Vasodilation procedure—Doxorubicin—liver cancer	0.0244	0.0244	CcSEcCtD
Calcium Gluceptate—Loss of consciousness—Sorafenib—liver cancer	0.0241	0.0241	CcSEcCtD
Calcium Gluceptate—Shock—Sorafenib—liver cancer	0.022	0.022	CcSEcCtD
Calcium Gluceptate—Anorexia—Sorafenib—liver cancer	0.0214	0.0214	CcSEcCtD
Calcium Gluceptate—Coma—Epirubicin—liver cancer	0.0212	0.0212	CcSEcCtD
Calcium Gluceptate—Coma—Doxorubicin—liver cancer	0.0196	0.0196	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Sorafenib—liver cancer	0.0195	0.0195	CcSEcCtD
Calcium Gluceptate—Constipation—Sorafenib—liver cancer	0.0192	0.0192	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Sorafenib—liver cancer	0.0165	0.0165	CcSEcCtD
Calcium Gluceptate—Asthenia—Sorafenib—liver cancer	0.0161	0.0161	CcSEcCtD
Calcium Gluceptate—Cardiac arrest—Epirubicin—liver cancer	0.016	0.016	CcSEcCtD
Calcium Gluceptate—Pruritus—Sorafenib—liver cancer	0.0158	0.0158	CcSEcCtD
Calcium Gluceptate—Diarrhoea—Sorafenib—liver cancer	0.0153	0.0153	CcSEcCtD
Calcium Gluceptate—Cardiac arrest—Doxorubicin—liver cancer	0.0148	0.0148	CcSEcCtD
Calcium Gluceptate—Dizziness—Sorafenib—liver cancer	0.0148	0.0148	CcSEcCtD
Calcium Gluceptate—Vomiting—Sorafenib—liver cancer	0.0142	0.0142	CcSEcCtD
Calcium Gluceptate—Nausea—Sorafenib—liver cancer	0.0133	0.0133	CcSEcCtD
Calcium Gluceptate—Bradycardia—Epirubicin—liver cancer	0.0119	0.0119	CcSEcCtD
Calcium Gluceptate—Bradycardia—Doxorubicin—liver cancer	0.011	0.011	CcSEcCtD
Calcium Gluceptate—Arrhythmia—Epirubicin—liver cancer	0.0104	0.0104	CcSEcCtD
Calcium Gluceptate—Dysgeusia—Epirubicin—liver cancer	0.00993	0.00993	CcSEcCtD
Calcium Gluceptate—Arrhythmia—Doxorubicin—liver cancer	0.00963	0.00963	CcSEcCtD
Calcium Gluceptate—Dysgeusia—Doxorubicin—liver cancer	0.00919	0.00919	CcSEcCtD
Calcium Gluceptate—Syncope—Epirubicin—liver cancer	0.0091	0.0091	CcSEcCtD
Calcium Gluceptate—Loss of consciousness—Epirubicin—liver cancer	0.00892	0.00892	CcSEcCtD
Calcium Gluceptate—Syncope—Doxorubicin—liver cancer	0.00842	0.00842	CcSEcCtD
Calcium Gluceptate—Confusional state—Epirubicin—liver cancer	0.00835	0.00835	CcSEcCtD
Calcium Gluceptate—Oedema—Epirubicin—liver cancer	0.00828	0.00828	CcSEcCtD
Calcium Gluceptate—Loss of consciousness—Doxorubicin—liver cancer	0.00825	0.00825	CcSEcCtD
Calcium Gluceptate—Shock—Epirubicin—liver cancer	0.00815	0.00815	CcSEcCtD
Calcium Gluceptate—Anorexia—Epirubicin—liver cancer	0.00789	0.00789	CcSEcCtD
Calcium Gluceptate—Hypotension—Epirubicin—liver cancer	0.00774	0.00774	CcSEcCtD
Calcium Gluceptate—Confusional state—Doxorubicin—liver cancer	0.00772	0.00772	CcSEcCtD
Calcium Gluceptate—Oedema—Doxorubicin—liver cancer	0.00766	0.00766	CcSEcCtD
Calcium Gluceptate—Shock—Doxorubicin—liver cancer	0.00754	0.00754	CcSEcCtD
Calcium Gluceptate—Paraesthesia—Epirubicin—liver cancer	0.00743	0.00743	CcSEcCtD
Calcium Gluceptate—Anorexia—Doxorubicin—liver cancer	0.0073	0.0073	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Epirubicin—liver cancer	0.0072	0.0072	CcSEcCtD
Calcium Gluceptate—Hypotension—Doxorubicin—liver cancer	0.00716	0.00716	CcSEcCtD
Calcium Gluceptate—Constipation—Epirubicin—liver cancer	0.00708	0.00708	CcSEcCtD
Calcium Gluceptate—Paraesthesia—Doxorubicin—liver cancer	0.00688	0.00688	CcSEcCtD
Calcium Gluceptate—Feeling abnormal—Epirubicin—liver cancer	0.00682	0.00682	CcSEcCtD
Calcium Gluceptate—Decreased appetite—Doxorubicin—liver cancer	0.00666	0.00666	CcSEcCtD
Calcium Gluceptate—Constipation—Doxorubicin—liver cancer	0.00655	0.00655	CcSEcCtD
Calcium Gluceptate—Feeling abnormal—Doxorubicin—liver cancer	0.00631	0.00631	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Epirubicin—liver cancer	0.0061	0.0061	CcSEcCtD
Calcium Gluceptate—Asthenia—Epirubicin—liver cancer	0.00594	0.00594	CcSEcCtD
Calcium Gluceptate—Pruritus—Epirubicin—liver cancer	0.00586	0.00586	CcSEcCtD
Calcium Gluceptate—Diarrhoea—Epirubicin—liver cancer	0.00566	0.00566	CcSEcCtD
Calcium Gluceptate—Hypersensitivity—Doxorubicin—liver cancer	0.00564	0.00564	CcSEcCtD
Calcium Gluceptate—Asthenia—Doxorubicin—liver cancer	0.0055	0.0055	CcSEcCtD
Calcium Gluceptate—Dizziness—Epirubicin—liver cancer	0.00547	0.00547	CcSEcCtD
Calcium Gluceptate—Pruritus—Doxorubicin—liver cancer	0.00542	0.00542	CcSEcCtD
Calcium Gluceptate—Vomiting—Epirubicin—liver cancer	0.00526	0.00526	CcSEcCtD
Calcium Gluceptate—Diarrhoea—Doxorubicin—liver cancer	0.00524	0.00524	CcSEcCtD
Calcium Gluceptate—Dizziness—Doxorubicin—liver cancer	0.00507	0.00507	CcSEcCtD
Calcium Gluceptate—Nausea—Epirubicin—liver cancer	0.00492	0.00492	CcSEcCtD
Calcium Gluceptate—Vomiting—Doxorubicin—liver cancer	0.00487	0.00487	CcSEcCtD
Calcium Gluceptate—Nausea—Doxorubicin—liver cancer	0.00455	0.00455	CcSEcCtD
